CCSD code D2630 – Osseous labyrinthectomy

Key takeaways

CCSD Code D2630 covers osseous labyrinthectomy, which removes the membranous labyrinth inside the bony labyrinth and ends all hearing and balance function in that ear.

Hearing loss in the operated ear is the planned result of the surgery. Operative notes must record it that way to meet medical necessity criteria.

Most private insurers require pre-authorization before the procedure, and a missing pre-auth reference is a common reason D2630 claims are denied.

Bupa bands D2630 as MAJOR+ 3, so check each insurer’s fee schedule and bundling rules before you bill.

Pabau’s claims management software blocks a D2630 claim from being sent until the membership number and authorization code are filled in.

CCSD Code D2630: Official descriptor and procedure scope

CCSD Code D2630 is assigned to osseous labyrinthectomy, defined by the CCSD schedule as surgical destruction of the membranous labyrinth within the bony labyrinth. It sits in the inner ear section of the schedule’s ear, nose and throat chapter. Bupa bands it MAJOR+ 3 in its fee schedule.

Our CCSD codes for billers index lists the neighboring inner ear and vestibular procedures. It helps when you need to rule out a close alternative.

The “osseous” qualifier matters clinically. Osseous labyrinthectomy requires access through the bony labyrinth itself, while a membranous-only approach stops short of it. That difference drives both the code selection and the documentation standard, because the operative report must confirm bony access.

What osseous labyrinthectomy involves: Clinical overview

Osseous labyrinthectomy is the surgical destruction of the membranous labyrinth, performed via a transmastoid approach. The surgeon drills through the mastoid bone to access the bony labyrinth, then removes the membranous structures within the semicircular canals and vestibule.

The cochlea is also disrupted during the procedure, so residual hearing is lost permanently. The surgeon plans for that loss from the start. Insurers read the operative note closely on this point. A note that calls the hearing loss a risk or an adverse event invites a medical necessity challenge.

• Approach: transmastoid, under general anesthesia
• Structures removed: membranous labyrinth within the bony labyrinth, including semicircular canal contents and vestibular neuroepithelium
• Cochlear impact: cochlear destruction occurs, producing permanent ipsilateral sensorineural deafness
• Vestibular outcome: complete ablation of ipsilateral vestibular function; central compensation typically follows over weeks to months
• Candidacy requirement: non-serviceable residual hearing is required before most insurers will authorize the procedure

Clinical indications: When is osseous labyrinthectomy performed?

Osseous labyrinthectomy is reserved for patients with end-stage vestibular dysfunction and non-serviceable hearing, where conservative and less destructive surgical options have already been exhausted. It is not a first-line treatment.

The primary indication is intractable Meniere’s disease (endolymphatic hydrops). That usually means disabling episodic vertigo that hasn’t responded to diet changes, diuretics, intratympanic steroid or gentamicin injections, or endolymphatic sac surgery.

Non-serviceable hearing is generally taken as a speech discrimination score below 50% or a pure-tone average above 50 dB. Insurers apply their own thresholds, so check current policy before citing specific values.

• Intractable Meniere’s disease unresponsive to medical management
• Disabling episodic vertigo following failed endolymphatic sac decompression or shunt
• End-stage unilateral vestibular dysfunction with non-serviceable residual hearing
• Failed intratympanic gentamicin therapy
• Chronic suppurative labyrinthitis with cochlear destruction

Each of these indications needs documented evidence in the clinical record. A bare reference to “intractable Meniere’s disease” in the operative report is rarely enough. The claim record has to show the treatment pathway the patient went through before surgery was proposed.

How to bill D2630: Claim submission steps

Billing D2630 through UK private insurers follows a set sequence. Skipping a step raises the denial risk on a code that already carries a heavy documentation load.

If Bupa is the patient’s insurer, start with the Bupa CCSD codes list, because Bupa publishes its own approved codes and fee schedule. For any insurer, confirm D2630 is on the covered code list before the procedure date.

1. Confirm cover and eligibility: verify the patient’s policy covers inpatient ENT surgery and that their insurer recognizes D2630.
2. Obtain prior authorization: send a pre-authorization request with audiological evidence of non-serviceable hearing, a documented treatment history, and the proposed procedure code. Most major UK private insurers require pre-auth for this procedure.
3. Select the correct CCSD code: use D2630 only where the operative plan confirms access through the bony labyrinth. If only membranous structures are targeted without osseous access, a different code may apply.
4. Pair with supporting diagnosis codes: include ICD-10 diagnosis codes that substantiate medical necessity (see the diagnosis code section below).
5. Complete the operative report before submission: it must confirm bony labyrinth access and describe the structures removed. It must also record hearing loss as an expected outcome.
6. Submit the claim with its supporting documents: insurer portals vary, so attach audiograms, prior treatment records, and the signed operative report as each one requires.

Practices billing several ENT surgeries a month can use claims software for specialists to catch a missing authorization code before submission. On a high-value claim like D2630, that saves a full resubmission cycle.

Documentation a D2630 claim needs

Private insurers review D2630 closely because the outcome is irreversible and the candidacy criteria are narrow. Medical billing compliance here means assembling the full record before the claim leaves the practice. The table lists what each document has to show.

Supporting ICD-10 diagnosis codes

The ICD-10 diagnosis code paired with CCSD Code D2630 must match the operative indication exactly. In UK private billing, ICD-10 codes follow the NHS Classifications Browser hierarchy, so check the current edition before submitting.

The codes above follow the international WHO classification. The NHS hierarchy may add local extensions, so confirm the code on the claim matches the primary indication in the clinical notes.

Adjacent CCSD codes: How D2630 differs from similar otology codes

Several otology procedures treat the same vertigo, so a neighboring code is an easy mistake. D2630 is set apart by bony labyrinth access combined with the planned, permanent hearing loss from cochlear involvement. Endolymphatic sac surgery, often tried before labyrinthectomy, bills separately under D2610.

Two questions settle the code, in a fixed order, as the diagram below shows.

The table below sets the four procedures side by side.

Commonly confused codes and unbundling risks

The costliest mix-up for D2630 is with vestibular neurectomy. Both treat intractable vertigo, and hearing is what separates them. A patient with serviceable hearing suits vestibular neurectomy, which preserves cochlear function. Billing D2630 for that patient triggers a medical necessity challenge, because destroying usable hearing isn’t clinically justified.

• Unbundling risk: endolymphatic sac procedures performed in an earlier admission should not be billed alongside D2630 on the same claim date
• Same-session coding: a mastoidectomy done as access for the labyrinthectomy may sit within the D2630 fee under some bundling rules. Check the insurer’s guidance before adding a separate mastoidectomy code
• Intratympanic injection codes: prior intratympanic gentamicin injections are separate procedures from a separate clinical episode and cannot be bundled with D2630

Prior authorization requirements for D2630

Treat pre-authorization as mandatory for D2630 with every UK private insurer. Osseous labyrinthectomy is inpatient surgery with a permanent outcome, and that combination draws the closest review most insurers apply.

Coverage policies and benefit levels change. The details above reflect general patterns in UK private healthcare, so check each insurer’s current provider guidance before relying on them for a patient’s claim.

Why D2630 claims get denied

D2630 has a narrower candidacy window than most ENT codes, so a single missing document can sink the claim. Effective denial management in healthcare starts with knowing the common denial reasons before the claim is lodged.

Resubmission and appeals for denied D2630 claims

A denial can be challenged. Most UK private insurers run a formal appeals process, and documentation-based D2630 denials are often reversed with the right additional evidence.

1. Identify the denial reason precisely: request the insurer’s written denial explanation, including the specific clinical or administrative criteria not met.
2. Gather additional clinical evidence: obtain a supplementary letter from the operating surgeon describing the procedure’s osseous nature and the medical necessity basis.
3. Write a medical necessity letter: the consultant should answer the insurer’s stated concern directly. If the denial cites serviceable hearing, for example, include the dated audiogram with its interpretation.
4. Submit within the appeal window: most insurers allow three to six months from the denial date, so check the appeals policy before lodging.
5. Document the appeal outcome: record the reference number, submission date, and outcome in the patient billing record regardless of the result.

Billing tips for osseous labyrinthectomy in private practice

ENT practices that bill D2630 regularly should build a pre-submission checklist into their workflow. The candidacy requirements are specific enough that a standard check catches the usual omissions before the claim goes out.

A clean claim submission for D2630 has the audiogram, treatment pathway, pre-auth reference and operative report filed and cross-referenced before it goes out. Assembling them after a denial arrives costs far more time.

• Template the operative note: build a D2630 note template for the surgeon. It should prompt for bony labyrinth access, the structures removed, and hearing loss as an expected outcome
• Pre-auth checklist: a one-page pre-auth pack with the audiogram date, speech discrimination score, treatment history summary, and proposed ICD-10 code cuts back-and-forth with insurers
• Track pre-auth reference numbers: record written reference numbers in the patient file at the time of approval, not retrospectively
• Verify diagnosis code version: confirm you are using the current ICD-10 edition before pairing with D2630 on the claim
• Review insurer fee schedules annually: insurers update CCSD fee schedules periodically, so check the D2630 fee and band at the start of each financial year

How Pabau keeps D2630 claims moving

Many ENT practices still assemble a D2630 claim from separate places. The pre-auth reference sits in an email, the audiogram in a scanned file, and the invoice in a billing tool that sees neither.

Pabau, the practice management system we build for private practices, keeps the patient’s insurer and policy on their record. When the invoice is ready, Pabau pulls the patient, procedure and insurer details into a pre-filled Healthcode submission.

Before the claim goes, Pabau checks that the membership number and authorization code are in place. If one is missing, the Send button stays disabled until someone adds it. Each claim then shows its status on one dashboard, so your billing team knows which D2630 claims still need chasing.

Send complete D2630 claims the first time

Pabau checks each claim for the membership number and authorization code before it goes to the insurer, then tracks it through to payment.

Book a demo

Conclusion

A D2630 claim is won or lost on paperwork that exists before the patient is admitted. When the audiogram, the dated treatment history and the written pre-auth reference are on file first, the insurer has little left to dispute.

The trade-off is effort up front. A D2630 operative note template and a one-page pre-auth pack take time to build once. After that, they stop the same wording and dating errors from coming back on every claim.

Book a demo to see how Pabau checks authorization codes and tracks every ENT claim from submission to payment.

Continue your research

Coding other ear procedures? CCSD Code D2030 explains how to bill grommet removal and what the operative note must name.

Frequently asked questions